Conjoint 538, Winter 2004
Minisymposium, Session I
RAD51
Henry-Mowatt et al., 2003
Alexiadis and Kadonaga, 2002
Pellegrini et al., 2002
RAD52/54
Essers et al., 2002
Solinger et al., 2002
BRCA1
Vandenberg et al., 2003
Dong et al., 2003
Rothfuss and Grompe, 2004
Taniguchi et al., 2003
BRCA2
Dong et al., 2003
Pellegrini
et al., 2002
Hirsch
et al., 2003
Howlett et al., 2002
Rothfuss and Grompe, 2004
Taniguchi et al., 2003
FANC
Meetei et al., 2003b
Hirsch et al., 2003
Levitus et al., 2003
Rothfuss and Grompe, 2004
Taniguchi et al., 2003
FANC D
Nakanishi et al., 2002
Houghtaling et al., 2003
Hirsch et al., 2003
Liu et al., 2003
Vandenberg et al., 2003
MSH2/MSH6/EXO1
Wei et al., 2003
XRCC1
Whitehouse et al., 2001
Vidal et al., 2001
Minisymposium, Session II
MUS81/EME1
Abraham et al., 2003
Boddy et al., 2001
Chen et al., 2001
Ogrunc and Sancar, 2003
WRN
Saintigny
et al., 2002
Baynton
et al., 2003
BLM
Wu and Hickson, 2003
Fabre et al., 2002
Meetei et al., 2003b
Karanjawala et al., 2002
Ma et al., 2002
DNA LIGASE 4
Frank et al., 2000
O'Driscoll et al., 2001
Messier et al., 2003
Jones and Gellert, 2003
H2AX
Bassing et al., 2003
Celeste et al., 2002
MRE11/RAD50/NBS1
Bender et al., 2002
Hopfner et al., 2002
Carson et al., 2003; Stracker et al., 2002
Bender et al., 2002
Uziel et al., 2003
Nakanishi et al., 2002
Minisymposium, Session III
AID
Petersen-Mahrt et al., 2002
Chaudhuri et al., 2003
Mangeat et al., 2003
Imai et al., 2003
Rada et al., 2002
Di Noia and Neuberger, 2002
Bresson and Fuchs, 2002
Zheng et al., 2003
Kannouche et al., 2002
Faili et al., 2002
RAD51 Paralogues
Liu et al., 2002
Masson et al., 2001
Sale et al., 2001
RAD51C/XRCC3
Liu et
al., 2004
Minisymposium, Session IV
Iben et al., 2002
Bradsher et al., 2002
Riedl et al., 2003
Tremeau-Bravard et al., 2003
Dubaele et al., 2003
CSB
Osterod et al., 2002
Bradsher et al., 2002
XPD
de Boer et al., 2002
Dubaele et al., 2003
Vermeulen et al., 2001
Zhu et al., 2003
Niedernhofer et al., 2001
XPG
Reardon and Sancar, 2002
Lee et al., 2002
Emmert et al., 2002
Lalle et al., 2002
Mallery et al., 2002
Meetei et al., 2003a
Jones and Gellert, 2003
Bachant et al., 2002
ATM
Bakkenist and Kastan, 2003
Spring et al., 2002
Carson et al., 2003
Uziel et al., 2003
ATR
Costanzo et al., 2003
Casper et al., 2002
P53
Zhu et al., 2002
Sorlie et al., 2003
Leslie et al., 2003; Overholtzer et al.,
2003
Liu et al., 2003
BIBLIOGRAPHY
Abraham,
J., Lemmers, B., Hande, M. P., Moynahan, M. E., Chahwan, C., Ciccia, A.,
Essers, J., Hanada, K., Chahwan, R., Khaw, A. K., et al. (2003). Eme1 is involved in DNA damage processing and
maintenance of genomic stability in mammalian cells. Embo J 22, 6137-6147.
Alexiadis,
V., and Kadonaga, J. T. (2002). Strand pairing by Rad54 and Rad51 is enhanced
by chromatin. Genes Dev 16, 2767-2771.
Bachant,
J., Alcasabas, A., Blat, Y., Kleckner, N., and Elledge, S. J. (2002). The
SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1
modification of DNA topoisomerase II. Mol Cell 9, 1169-1182.
Bakkenist,
C. J., and Kastan, M. B. (2003). DNA damage activates ATM through intermolecular
autophosphorylation and dimer dissociation. Nature 421, 499-506.
Bassing,
C. H., Suh, H., Ferguson, D. O., Chua, K. F., Manis, J., Eckersdorff, M.,
Gleason, M., Bronson, R., Lee, C., and Alt, F. W. (2003). Histone H2AX: a
dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114, 359-370.
Baynton,
K., Otterlei, M., Bjoras, M., von Kobbe, C., Bohr, V. A., and Seeberg, E.
(2003). WRN interacts physically and functionally with the recombination
mediator protein RAD52. J Biol Chem 278,
36476-36486.
Bender,
C. F., Sikes, M. L., Sullivan, R., Huye, L. E., Le Beau, M. M., Roth, D. B.,
Mirzoeva, O. K., Oltz, E. M., and Petrini, J. H. (2002). Cancer predisposition
and hematopoietic failure in Rad50(S/S) mice. Genes Dev 16, 2237-2251.
Boddy,
M. N., Gaillard, P. H., McDonald, W. H., Shanahan, P., Yates, J. R., 3rd, and
Russell, P. (2001). Mus81-Eme1 are essential components of a Holliday junction
resolvase. Cell 107, 537-548.
Bradsher,
J., Auriol, J., Proietti de Santis, L., Iben, S., Vonesch, J. L., Grummt, I.,
and Egly, J. M. (2002). CSB is a component of RNA pol I transcription. Mol Cell
10, 819-829.
Bresson,
A., and Fuchs, R. P. (2002). Lesion bypass in yeast cells: Pol eta participates
in a multi-DNA polymerase process. Embo J 21, 3881-3887.
Carson,
C. T., Schwartz, R. A., Stracker, T. H., Lilley, C. E., Lee, D. V., and
Weitzman, M. D. (2003). The Mre11 complex is required for ATM activation and
the G(2)/M checkpoint. Embo J 22,
6610-6620.
Casper,
A. M., Nghiem, P., Arlt, M. F., and Glover, T. W. (2002). ATR regulates fragile
site stability. Cell 111, 779-789.
Celeste,
A., Petersen, S., Romanienko, P. J., Fernandez-Capetillo, O., Chen, H. T.,
Sedelnikova, O. A., Reina-San-Martin, B., Coppola, V., Meffre, E.,
Difilippantonio, M. J., et al. (2002).
Genomic instability in mice lacking histone H2AX. Science 296, 922-927.
Chaudhuri,
J., Tian, M., Khuong, C., Chua, K., Pinaud, E., and Alt, F. W. (2003).
Transcription-targeted DNA deamination by the AID antibody diversification
enzyme. Nature 422, 726-730.
Chen,
X. B., Melchionna, R., Denis, C. M., Gaillard, P. H., Blasina, A., Van de
Weyer, I., Boddy, M. N., Russell, P., Vialard, J., and McGowan, C. H. (2001).
Human Mus81-associated endonuclease cleaves Holliday junctions in vitro. Mol
Cell 8, 1117-1127.
Costanzo,
V., Shechter, D., Lupardus, P. J., Cimprich, K. A., Gottesman, M., and Gautier,
J. (2003). An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits
initiation of DNA replication. Mol Cell 11, 203-213.
de
Boer, J., Andressoo, J. O., de Wit, J., Huijmans, J., Beems, R. B., van Steeg,
H., Weeda, G., van der Horst, G. T., van Leeuwen, W., Themmen, A. P., et al. (2002). Premature aging in mice deficient in DNA repair
and transcription. Science 296,
1276-1279.
Di
Noia, J., and Neuberger, M. S. (2002). Altering the pathway of immunoglobulin
hypermutation by inhibiting uracil-DNA glycosylase. Nature 419, 43-48.
Dong,
Y., Hakimi, M. A., Chen, X., Kumaraswamy, E., Cooch, N. S., Godwin, A. K., and
Shiekhattar, R. (2003). Regulation of BRCC, a holoenzyme complex containing
BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Mol
Cell 12, 1087-1099.
Dubaele,
S., Proietti De Santis, L., Bienstock, R. J., Keriel, A., Stefanini, M., Van
Houten, B., and Egly, J. M. (2003). Basal transcription defect discriminates
between xeroderma pigmentosum and trichothiodystrophy in XPD patients. Mol Cell
11, 1635-1646.
Emmert. S., Slor, H., Busch, D.B.,
Batko, S., Albert, R.B., Coleman, D., Khan, S.G., Abu-Libdeh, B., DiGiovanna,
J.J., Cunningham, B.B., Lee, M.M., Crollick, J., Inui, H., Ueda, T., Hedayati,
M., Grossman, L., Shahlavi, T., Cleaver, J.E., Kraemer, K.H. (2002)
Relationship of neurologic degeneration to genotype in three xeroderma
pigmentosum group G patients. J Invest Dermatol. 118, 972-82. Erratum in: J Invest Dermatol.
(2003
) 120, 173..
Essers,
J., Houtsmuller, A. B., van Veelen, L., Paulusma, C., Nigg, A. L., Pastink, A.,
Vermeulen, W., Hoeijmakers, J. H., and Kanaar, R. (2002). Nuclear dynamics of
RAD52 group homologous recombination proteins in response to DNA damage. Embo J
21, 2030-2037.
Fabre,
F., Chan, A., Heyer, W. D., and Gangloff, S. (2002). Alternate pathways
involving Sgs1/Top3, Mus81/ Mms4, and Srs2 prevent formation of toxic
recombination intermediates from single-stranded gaps created by DNA
replication. Proc Natl Acad Sci U S A 99,
16887-16892.
Faili,
A., Aoufouchi, S., Flatter, E., Gueranger, Q., Reynaud, C. A., and Weill, J. C.
(2002). Induction of somatic hypermutation in immunoglobulin genes is dependent
on DNA polymerase iota. Nature 419,
944-947.
Frank,
K. M., Sharpless, N. E., Gao, Y., Sekiguchi, J. M., Ferguson, D. O., Zhu, C.,
Manis, J. P., Horner, J., DePinho, R. A., and Alt, F. W. (2000). DNA ligase IV
deficiency in mice leads to defective neurogenesis and embryonic lethality via
the p53 pathway. Mol Cell 5, 993-1002.
Goss,
K. H., Risinger, M. A., Kordich, J. J., Sanz, M. M., Straughen, J. E., Slovek,
L. E., Capobianco, A. J., German, J., Boivin, G. P., and Groden, J. (2002).
Enhanced tumor formation in mice heterozygous for Blm mutation. Science 297, 2051-2053.
Henry-Mowatt,
J., Jackson, D., Masson, J. Y., Johnson, P. A., Clements, P. M., Benson, F. E.,
Thompson, L. H., Takeda, S., West, S. C., and Caldecott, K. W. (2003). XRCC3
and Rad51 modulate replication fork progression on damaged vertebrate
chromosomes. Mol Cell 11, 1109-1117.
Hirsch,
B., Shimamura, A., Moreau, L., Baldinger, S., Hag-Alshiekh, M., Bostrom, B.,
Sencer, S., and D'Andrea, A. D. (2003). Biallelic BRCA2/FANCD1 mutations:
association with spontaneous chromosomal instability and solid tumors of
childhood. Blood.
Hopfner,
K. P., Craig, L., Moncalian, G., Zinkel, R. A., Usui, T., Owen, B. A., Karcher,
A., Henderson, B., Bodmer, J. L., McMurray, C. T., et al. (2002). The Rad50 zinc-hook is a structure joining Mre11
complexes in DNA recombination and repair. Nature 418, 562-566.
Houghtaling,
S., Timmers, C., Noll, M., Finegold, M. J., Jones, S. N., Meyn, M. S., and
Grompe, M. (2003). Epithelial cancer in Fanconi anemia complementation group D2
(Fancd2) knockout mice. Genes Dev 17,
2021-2035.
Howlett,
N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., De Die-Smulders, C.,
Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002). Biallelic inactivation of BRCA2 in Fanconi anemia.
Science 297, 606-609.
Iben,
S., Tschochner, H., Bier, M., Hoogstraten, D., Hozak, P., Egly, J. M., and
Grummt, I. (2002). TFIIH plays an essential role in RNA polymerase I
transcription. Cell 109, 297-306.
Imai,
K., Slupphaug, G., Lee, W. I., Revy, P., Nonoyama, S., Catalan, N., Yel, L.,
Forveille, M., Kavli, B., Krokan, H. E., et al. (2003). Human uracil-DNA glycosylase deficiency associated
with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol
4, 1023-1028.
Jones,
J. M., and Gellert, M. (2003). Autoubiquitylation of the V(D)J recombinase
protein RAG1. Proc Natl Acad Sci U S A.
Kannouche,
P., Fernandez de Henestrosa, A. R., Coull, B., Vidal, A. E., Gray, C., Zicha,
D., Woodgate, R., and Lehmann, A. R. (2002). Localization of DNA polymerases
eta and iota to the replication machinery is tightly co-ordinated in human
cells. Embo J 21, 6246-6256.
Karanjawala,
Z. E., Adachi, N., Irvine, R. A., Oh, E. K., Shibata, D., Schwarz, K., Hsieh,
C. L., and Lieber, M. R. (2002). The embryonic lethality in DNA ligase
IV-deficient mice is rescued by deletion of Ku: implications for unifying the
heterogeneous phenotypes of NHEJ mutants. DNA Repair (Amst) 1, 1017-1026.
Lalle
P, Nouspikel T, Constantinou A, Thorel F, Clarkson SG. (2002) The founding
members of xeroderma pigmentosum group G produce XPG proteiN with severely
impaired endonuclease activity. J Invest Dermatol. 118, 344-51.
Lee,
S. K., Yu, S. L., Prakash, L., and Prakash, S. (2002). Requirement of yeast
RAD2, a homolog of human XPG gene, for efficient RNA polymerase II
transcription. implications for Cockayne syndrome. Cell 109, 823-834.
Leslie,
A., Pratt, N. R., Gillespie, K., Sales, M., Kernohan, N. M., Smith, G., Wolf,
C. R., Carey, F. A., and Steele, R. J. (2003). Mutations of APC, K-ras, and p53
are associated with specific chromosomal aberrations in colorectal
adenocarcinomas. Cancer Res 63,
4656-4661.
Levitus,
M., Rooimans, M. A., Steltenpool, J., Cool, N. F., Oostra, A. B., Mathew, C.
G., Hoatlin, M. E., Waisfisz, Q., Arwert, F., De Winter, J. P., and Joenje, H.
(2003). Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes.
Blood.
Liu,
N., Schild, D., Thelen, M. P., and Thompson, L. H. (2002). Involvement of
Rad51C in two distinct protein complexes of Rad51 paralogs in human cells.
Nucleic Acids Res 30, 1009-1015.
Liu,
T. X., Howlett, N. G., Deng, M., Langenau, D. M., Hsu, K., Rhodes, J., Kanki,
J. P., D'Andrea, A. D., and Look, A. T. (2003). Knockdown of zebrafish Fancd2
causes developmental abnormalities via p53-dependent apoptosis. Dev Cell 5, 903-914.
Liu,
Y., Masson, J. Y., Shah, R., O'Regan, P., and West, S. C. (2004). RAD51C is
required for Holliday junction processing in mammalian cells. Science 303.
Ma,
Y., Pannicke, U., Schwarz, K., and Lieber, M. R. (2002). Hairpin opening and
overhang processing by an Artemis/DNA-dependent protein kinase complex in
nonhomologous end joining and V(D)J recombination. Cell 108, 781-794.
Mallery,
D. L., Vandenberg, C. J., and Hiom, K. (2002). Activation of the E3 ligase
function of the BRCA1/BARD1 complex by polyubiquitin chains. Embo J 21, 6755-6762.
Mangeat,
B., Turelli, P., Caron, G., Friedli, M., Perrin, L., and Trono, D. (2003).
Broad antiretroviral defence by human APOBEC3G through lethal editing of
nascent reverse transcripts. Nature 424,
99-103.
Masson,
J. Y., Tarsounas, M. C., Stasiak, A. Z., Stasiak, A., Shah, R., McIlwraith, M.
J., Benson, F. E., and West, S. C. (2001). Identification and purification of
two distinct complexes containing the five RAD51 paralogs. Genes Dev 15, 3296-3307.
Meetei,
A. R., de Winter, J. P., Medhurst, A. L., Wallisch, M., Waisfisz, Q., van de
Vrugt, H. J., Oostra, A. B., Yan, Z., Ling, C., Bishop, C. E., et al. (2003a). A novel ubiquitin ligase is deficient in Fanconi
anemia. Nat Genet 35, 165-170.
Meetei,
A. R., Sechi, S., Wallisch, M., Yang, D., Young, M. K., Joenje, H., Hoatlin, M.
E., and Wang, W. (2003b). A multiprotein nuclear complex connects Fanconi
anemia and Bloom syndrome. Mol Cell Biol 23, 3417-3426.
Messier,
T. L., O'Neill, J. P., Hou, S. M., Nicklas, J. A., and Finette, B. A. (2003).
In vivo transposition mediated by V(D)J recombinase in human T lymphocytes.
Embo J 22, 1381-1388.
Nakanishi,
K., Taniguchi, T., Ranganathan, V., New, H. V., Moreau, L. A., Stotsky, M.,
Mathew, C. G., Kastan, M. B., Weaver, D. T., and D'Andrea, A. D. (2002).
Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol 4, 913-920.
Niedernhofer,
L. J., Essers, J., Weeda, G., Beverloo, B., de Wit, J., Muijtjens, M., Odijk,
H., Hoeijmakers, J. H., and Kanaar, R. (2001). The structure-specific
endonuclease Ercc1-Xpf is required for targeted gene replacement in embryonic
stem cells. Embo J 20, 6540-6549.
O'Driscoll,
M., Cerosaletti, K. M., Girard, P. M., Dai, Y., Stumm, M., Kysela, B., Hirsch,
B., Gennery, A., Palmer, S. E., Seidel, J., et al. (2001). DNA ligase IV mutations identified in patients
exhibiting developmental delay and immunodeficiency. Mol Cell 8, 1175-1185.
Ogrunc,
M., and Sancar, A. (2003). Identification and characterization of human
MUS81-MMS4 structure-specific endonuclease. J Biol Chem 278, 21715-21720.
Osterod,
M., Larsen, E., Le Page, F., Hengstler, J. G., Van Der Horst, G. T., Boiteux,
S., Klungland, A., and Epe, B. (2002). A global DNA repair mechanism involving
the Cockayne syndrome B (CSB) gene product can prevent the in vivo accumulation
of endogenous oxidative DNA base damage. Oncogene 21, 8232-8239.
Overholtzer,
M., Rao, P. H., Favis, R., Lu, X. Y., Elowitz, M. B., Barany, F., Ladanyi, M.,
Gorlick, R., and Levine, A. J. (2003). The presence of p53 mutations in human
osteosarcomas correlates with high levels of genomic instability. Proc Natl
Acad Sci U S A 100, 11547-11552.
Pellegrini,
L., Yu, D. S., Lo, T., Anand, S., Lee, M., Blundell, T. L., and Venkitaraman,
A. R. (2002). Insights into DNA recombination from the structure of a
RAD51-BRCA2 complex. Nature 420,
287-293.
Petersen-Mahrt,
S. K., Harris, R. S., and Neuberger, M. S. (2002). AID mutates E. coli
suggesting a DNA deamination mechanism for antibody diversification. Nature
418, 99-104.
Rada,
C., Williams, G. T., Nilsen, H., Barnes, D. E., Lindahl, T., and Neuberger, M.
S. (2002). Immunoglobulin isotype switching is inhibited and somatic
hypermutation perturbed in UNG-deficient mice. Curr Biol 12, 1748-1755.
Reardon,
J. T., and Sancar, A. (2002). Molecular anatomy of the human excision nuclease
assembled at sites of DNA damage. Mol Cell Biol 22, 5938-5945.
Riedl,
T., Hanaoka, F., and Egly, J. M. (2003). The comings and goings of nucleotide
excision repair factors on damaged DNA. Embo J 22, 5293-5303.
Rothfuss,
A., and Grompe, M. (2004). Repair Kinetics of Genomic Interstrand DNA
Cross-Links: Evidence for DNA Double-Strand Break-Dependent Activation of the
Fanconi Anemia/BRCA Pathway. Mol Cell Biol 24, 123-134.
Saintigny,
Y., Makienko, K., Swanson, C., Emond, M. J., and Monnat, R. J., Jr. (2002).
Homologous recombination resolution defect in werner syndrome. Mol Cell Biol
22, 6971-6978.
Sale,
J. E., Calandrini, D. M., Takata, M., Takeda, S., and Neuberger, M. S. (2001).
Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic
hypermutation. Nature 412, 921-926.
Solinger,
J. A., Kiianitsa, K., and Heyer, W. D. (2002). Rad54, a Swi2/Snf2-like
recombinational repair protein, disassembles Rad51:dsDNA filaments. Mol Cell
10, 1175-1188.
Sorlie,
T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S.,
Johnsen, H., Pesich, R., Geisler, S., et al. (2003). Repeated observation of breast tumor subtypes in
independent gene expression data sets. Proc Natl Acad Sci U S A 100, 8418-8423.
Spring,
K., Ahangari, F., Scott, S. P., Waring, P., Purdie, D. M., Chen, P. C.,
Hourigan, K., Ramsay, J., McKinnon, P. J., Swift, M., and Lavin, M. F. (2002).
Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia,
have heightened susceptibility to cancer. Nat Genet 32, 185-190.
Stracker,
T. H., Carson, C. T., and Weitzman, M. D. (2002). Adenovirus oncoproteins
inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418, 348-352.
Taniguchi,
T., Tischkowitz, M., Ameziane, N., Hodgson, S. V., Mathew, C. G., Joenje, H.,
Mok, S. C., and D'Andrea, A. D. (2003). Disruption of the Fanconi anemia-BRCA
pathway in cisplatin-sensitive ovarian tumors. Nat Med 9, 568-574.
Tremeau-Bravard,
A., Riedl, T., Egly, J. M., and Dahmus, M. E. (2003). Fate of RNA polymerase II
stalled at a cisplatin lesion. J Biol Chem.
Uziel,
T., Lerenthal, Y., Moyal, L., Andegeko, Y., Mittelman, L., and Shiloh, Y.
(2003). Requirement of the MRN complex for ATM activation by DNA damage. Embo J
22, 5612-5621.
Vandenberg,
C. J., Gergely, F., Ong, C. Y., Pace, P., Mallery, D. L., Hiom, K., and Patel,
K. J. (2003). BRCA1-independent ubiquitination of FANCD2. Mol Cell 12, 247-254.
Vermeulen,
W., Rademakers, S., Jaspers, N. G., Appeldoorn, E., Raams, A., Klein, B.,
Kleijer, W. J., Hansen, L. K., and Hoeijmakers, J. H. (2001). A
temperature-sensitive disorder in basal transcription and DNA repair in humans.
Nat Genet 27, 299-303.
Vidal,
A. E., Boiteux, S., Hickson, I. D., and Radicella, J. P. (2001). XRCC1 coordinates
the initial and late stages of DNA abasic site repair through protein-protein
interactions. Embo J 20, 6530-6539.
Wei,
K., Clark, A. B., Wong, E., Kane, M. F., Mazur, D. J., Parris, T., Kolas, N.
K., Russell, R., Hou, H., Jr., Kneitz, B., et al. (2003). Inactivation of Exonuclease 1 in mice results in
DNA mismatch repair defects, increased cancer susceptibility, and male and
female sterility. Genes Dev 17,
603-614.
Whitehouse,
C. J., Taylor, R. M., Thistlethwaite, A., Zhang, H., Karimi-Busheri, F., Lasko,
D. D., Weinfeld, M., and Caldecott, K. W. (2001). XRCC1 stimulates human
polynucleotide kinase activity at damaged DNA termini and accelerates DNA
single-strand break repair. Cell 104,
107-117.
Wu,
L., and Hickson, I. D. (2003). The Bloom's syndrome helicase suppresses
crossing over during homologous recombination. Nature 426, 870-874.
Zheng,
H., Wang, X., Warren, A. J., Legerski, R. J., Nairn, R. S., Hamilton, J. W.,
and Li, L. (2003). Nucleotide excision repair- and polymerase eta-mediated
error-prone removal of mitomycin C interstrand cross-links. Mol Cell Biol 23, 754-761.
Zhu,
C., Mills, K. D., Ferguson, D. O., Lee, C., Manis, J., Fleming, J., Gao, Y.,
Morton, C. C., and Alt, F. W. (2002). Unrepaired DNA breaks in p53-deficient
cells lead to oncogenic gene amplification subsequent to translocations. Cell
109, 811-821.
Zhu, X. D., Niedernhofer, L.,
Kuster, B., Mann, M., Hoeijmakers, J. H., and de Lange, T. (2003). ERCC1/XPF
removes the 3' overhang from uncapped telomeres and represses formation of
telomeric DNA-containing double minute chromosomes. Mol Cell 12, 1489-1498.